Laser ‘Dusting’ Compares Favorably As Kidney Stone Treatment
Technique could reduce the need for ureteral access sheaths.
Technique could reduce the need for ureteral access sheaths.
These same patients, however, had less intense detrusor overactivity, urodynamic evaluation revealed.
In particular, no hepatic toxicities emerged during a 52-week phase 3 trial.
Reasons are unclear, but use of testosterone and other performance enhance drugs could be a contributing factor.
Only this histologic variant occurs at a significantly higher incidence in renal allograft recipients than the non-transplant population.
In a study, use of the medication was associated with a significant 61% decreased risk.
Physician expressions of sympathy and regret appear to encourage quicker settlements.
Urologists and gynecologists are 49% and 30% more likely than primary care doctors to prescribe second-generation agents.
Use of the lipid-lowering drugs is associated with 43% and 47% decreased odds of new stones in recurrent stone formers and stone naïve patients.